A phase I factorial design study of dose-dense temozolomide alone and in combination with thalidomide, isotretinoin, and/or celecoxib as postchemoradiation adjuvant therapy for newly diagnosed glioblastoma

External beam radiation therapy (XRT) with concomitant temozolomide and 6 cycles of adjuvant temozolomide (5/28-day schedule) improves survival in patients with newly diagnosed glioblastoma compared with XRT alone. Studies suggest that dose-dense temozolomide schedules and addition of cytostatic age...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Gilbert, Mark R., Gonzalez, Javier, Hunter, Kathy, Hess, Kenneth, Giglio, Pierre, Chang, Eric, Puduvalli, Vinay, Groves, Morris D., Colman, Howard, Conrad, Charles, Levin, Victor, Woo, Shaio, Mahajan, Anita, de Groot, John, Yung, W.K. Alfred
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2010
Предметы:
Clinical Investigations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3098026/
https://ncbi.nlm.nih.gov/pubmed/20729242
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noq100
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы